Cargando…

Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication

BACKGROUND & AIMS: In experimental models, alcohol induces acute changes in lipid metabolism that cause hepatocyte lipoapoptosis and inflammation. Here we study human hepatic lipid turnover during controlled alcohol intoxication. METHODS: We studied 39 participants with 3 distinct hepatic phenot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Israelsen, Mads, Kim, Min, Suvitaival, Tommi, Madsen, Bjørn Stæhr, Hansen, Camilla Dalby, Torp, Nikolaj, Trost, Kajetan, Thiele, Maja, Hansen, Torben, Legido-Quigley, Cristina, Krag, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350545/ https://www.ncbi.nlm.nih.gov/pubmed/34401690 http://dx.doi.org/10.1016/j.jhepr.2021.100325

Ejemplares similares

Describing the fecal metabolome in cryogenically collected samples from healthy participants
por: Trošt, Kajetan, et al.
Publicado: (2020)

Lipidomics of human adipose tissue reveals diversity between body areas
por: Al-Sari, Naba, et al.
Publicado: (2020)

Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post‐hoc analysis of a randomized crossover trial
por: Al‐Sari, Naba, et al.
Publicado: (2021)

Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
por: Curovic, Viktor Rotbain, et al.
Publicado: (2020)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
por: Hansen, Christian S., et al.
Publicado: (2022)

High-Throughput UHPLC-MS to Screen Metabolites in Feces for Gut Metabolic Health
por: de Zawadzki, Andressa, et al.
Publicado: (2022)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review
por: Suvitaival, Tommi
Publicado: (2020)

Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
por: Ferreira-Divino, Luis F., et al.
Publicado: (2022)

Lipidomics and the quest for brainy lipids
por: Legido-Quigley, Cristina
Publicado: (2021)

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD
por: Wang, Junling, et al.
Publicado: (2016)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
por: Takeuchi, Masayoshi, et al.
Publicado: (2017)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021)

Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Zobel, Emilie H, et al.
Publicado: (2021)

Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
por: Al-Sari, Naba, et al.
Publicado: (2022)

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal
por: Kjærgaard, Maria, et al.
Publicado: (2017)

Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD
por: Fan, Simin, et al.
Publicado: (2022)

Deregulation of the Purine Pathway in Pre-Transplant Liver Biopsies Is Associated with Graft Function and Survival after Transplantation
por: Xu, Jin, et al.
Publicado: (2020)

Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort
por: Tapia, German, et al.
Publicado: (2021)

The prevalence and risk factors for cognitive impairment in obesity and NAFLD
por: Wernberg, Charlotte W., et al.
Publicado: (2023)

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
por: Wretlind, Asger, et al.
Publicado: (2023)

Molecular Atlas of Postnatal Mouse Heart Development
por: Talman, Virpi, et al.
Publicado: (2018)

Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
por: Lovric, Alen, et al.
Publicado: (2018)

Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes
por: Varga, Tibor V., et al.
Publicado: (2020)

Microelectrode Array With Transparent ALD TiN Electrodes
por: Ryynänen, Tomi, et al.
Publicado: (2019)

Stronger findings from mass spectral data through multi-peak modeling
por: Suvitaival, Tommi, et al.
Publicado: (2014)

Stronger findings for metabolomics through Bayesian modeling of multiple peaks and compound correlations
por: Suvitaival, Tommi, et al.
Publicado: (2014)

Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment
por: Zhang, Jiayuan, et al.
Publicado: (2023)

Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease
por: Elingaard-Larsen, Line O., et al.
Publicado: (2023)

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
por: Xu, Jin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_81e43lpmfgr0cr90kp9jdnl7of